TechnologyThe proprietary AI platform PEDAL has demonstrated the potential to identify biomarkers in cancer patients, making it an attractive licensing target.

Bears Say

Financial PerformancePredictive Oncology reported lower than expected revenue for 3Q24, indicating potential financial challenges.

Strategic UncertaintyThe company is undergoing a strategic review, which includes evaluating alternatives like a sale of the company or its assets, creating uncertainty.

AGPU FAQ

What was Axe Compute Inc’s price range in the past 12 months?

Axe Compute Inc lowest stock price was $3.88 and its highest was $45.90 in the past 12 months.

What is Axe Compute Inc’s market cap?

Axe Compute Inc’s market cap is $23.01M.

When is Axe Compute Inc’s upcoming earnings report date?

Axe Compute Inc’s upcoming earnings report date is Apr 08, 2026 which is in 106 days.

How were Axe Compute Inc’s earnings last quarter?

Axe Compute Inc released its earnings results on Nov 14, 2025. The company reported -$107.25 earnings per share for the quarter, missing the consensus estimate of N/A by -$107.25.

Is Axe Compute Inc overvalued?

According to Wall Street analysts Axe Compute Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Axe Compute Inc pay dividends?

Axe Compute Inc does not currently pay dividends.

What is Axe Compute Inc’s EPS estimate?

Axe Compute Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Axe Compute Inc have?

Axe Compute Inc has 3,393,516 shares outstanding.

What happened to Axe Compute Inc’s price movement after its last earnings report?

Axe Compute Inc reported an EPS of -$107.25 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.173%.

Which hedge fund is a major shareholder of Axe Compute Inc?

Currently, no hedge funds are holding shares in AGPU

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Axe Compute Inc

Axe Compute Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. Predictive Oncology Inc. has a strategic collaboration with Every Cure to identify and prioritize drugs for repurposing. The company was formerly known as Predictive Oncology Inc. and changed its name to Axe Compute Inc. in December 2025. Axe Compute Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.